Evidence map›Paper›PMID 41603881›Full record

ArticleJMIR formative research2026

A Telehealth-Based Behavioral Intervention for Cancer-Related Cognitive Decline in Older Adults Undergoing Systemic Therapy for Breast Cancer: Development and Usability Testing.

J MacLaren Kelly, Lucia Berkhof, Oscar Y Franco-Rocha, Lewis Mustian, Valerie Targia, Jessica Bauer, Jessica Mortimer, Grace DiGiovanni, Daniel Millstein, Kassandra Scioli and 7 more

Abstract read
In one paragraph

Article in JMIR formative research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

J MacLaren Kelly *Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, United States.ORCID 0000-0003-4423-8670
Lucia Berkhof *Roberts Wesleyan University, Rochester, NY, United States.ORCID 0009-0000-4763-1131
Oscar Y Franco-RochaJames P. Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Box 601, Rochester, NY, 14624, United States, 1 585-275-5823.ORCID 0000-0002-5547-1518
Lewis MustianPatient Advocate Research Collaborator Group, SCOREboard, Rochester, NY, United States.ORCID 0009-0002-2567-0070
Valerie TargiaPatient Advocate Research Collaborator Group, SCOREboard, Rochester, NY, United States.ORCID 0009-0009-6514-1027
Jessica BauerJames P. Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Box 601, Rochester, NY, 14624, United States, 1 585-275-5823.ORCID 0009-0005-7565-2518
Jessica MortimerJames P. Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Box 601, Rochester, NY, 14624, United States, 1 585-275-5823.ORCID 0009-0004-9121-9127
Grace DiGiovanniCollege of Osteopathic Medicine, University of New England, Biddeford, ME, United States.ORCID 0009-0001-5794-2897
Daniel MillsteinDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY, United States.ORCID 0000-0003-0204-3883
Kassandra ScioliHealth Services, University of Waterloo, Waterloo, ON, Canada.ORCID 0009-0004-1858-7492
Heidi DAurizioJames P. Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Box 601, Rochester, NY, 14624, United States, 1 585-275-5823.ORCID 0009-0005-9385-3348
Lauren DeCaporale-RyanDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY, United States.ORCID 0000-0001-7228-2447
Supriya MohileJames P. Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Box 601, Rochester, NY, 14624, United States, 1 585-275-5823.ORCID 0000-0003-0867-327X
Michelle JanelsinsDepartment of Surgery, University of Rochester Medical Center, Rochester, NY, United States.ORCID 0000-0003-2258-7247
Robert J FergusonSt Jude Children's Research Hospital, Memphis, TN, United States.ORCID 0000-0001-9711-022X
Alissa HustonJames P. Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Box 601, Rochester, NY, 14624, United States, 1 585-275-5823.ORCID 0009-0004-5247-9567
Allison MagnusonJames P. Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Box 601, Rochester, NY, 14624, United States, 1 585-275-5823.ORCID 0000-0002-0968-8265

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
A Patient-Oriented Research Program in Geriatric OncologyK24AG056589 · NIA · UNIVERSITY OF ROCHESTER · PI Supriya G. Mohile · 2018 to 2026
$1.5M
Mitigating Cancer-Related Cognitive Dysfunction in Older Adults with Breast CancerK76AG064394 · NIA · UNIVERSITY OF ROCHESTER · PI MAGNUSON, ALLISON MARIAN · 2019 to 2023
$1.3M
NCI NIH HHS UG1 CA189961NIA NIH HHS K24 AG056589NIA NIH HHS K76 AG064394
6 · The paper itself

Abstract

Background: Cancer-related cognitive decline (CRCD) is a significant problem; interventions are needed to mitigate CRCD for older adults (aged ≥65 years). Objective: Our objective was to develop and evaluate the usability of Memory and Attention Adaptation Training-Geriatrics (MAAT-G), a CRCD intervention for older adults with breast cancer undergoing systemic treatment. Methods: We conducted an intervention adaptation study to develop MAAT-G. MAAT-G is a cognitive behavioral therapy-based intervention delivered by a health professional over the course of 10 weekly individual workshops via videoconferencing. To develop MAAT-G, the contextual, cohort-based, maturity, and specific challenge framework was used for preliminary adaptations. Patient advocate collaborators guided further refinement, reviewing MAAT-G workshop content, the participant workbook, and intervention delivery via videoconferencing to optimize relevance and usability for older adults. The usability of MAAT-G and its videoconferencing delivery were subsequently evaluated in 4 older adults with breast cancer using the System Usability Scale (score range 0-100; >67 being above average) and through semistructured qualitative interviews. Results: Numerous adaptations were made to address the unique needs of older patients using the contextual, cohort-based, maturity, and specific challenge framework and patient advocate feedback. Usability testing included 4 female patients with breast cancer (mean age 73.3, SD 3.77; range 67-77 years). Patients were receiving systemic therapy (2 receiving adjuvant therapy and 2 receiving advanced-stage disease therapy). One patient had an educational level lower than high school; 3 had some college education or higher. All 4 patients completed study procedures, including 10 MAAT-G workshop sessions (100% intervention adherence). The mean System Usability Scale score was 90.6 (SD 13.51), indicating good usability. Conclusions: MAAT-G is a behavioral intervention developed to mitigate CRCD. It is designed specifically for older adults and showed above-average usability in this population.

Indexed as

Breast NeoplasmsCognitive Behavioral TherapyCognitive DysfunctionAgedAged, 80 and overFemaleHumansMental Health TeletherapyTelemedicineVideoconferencingcancer-related cognitive declinecognitiongeriatric oncologyolder adultstelehealth or videoconferencing

Identifiers

PMID41603881
PMCPMC12850034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.